Viatris sees bigger future in biosimilars — and a bigger return By: Pittsburgh Business Times via Business Journals March 01, 2021 at 11:04 AM EST Viatris, and Mylan before it, saw biosimilars as a way to grow its business and create a differentiation among its competitors. Read More >>